SONN logo

SONN
Sonnet BioTherapeutics Holdings Inc

23,571
Mkt Cap
$41.9M
Volume
1.59M
52W High
$19.30
52W Low
$1.08
PE Ratio
-0.72
SONN Fundamentals
Price
$5.81
Prev Close
$5.40
Open
$4.43
50D MA
$4.88
Beta
0.80
Avg. Volume
510,227.61
EPS (Annual)
-$11.35
P/B
-6.48
Rev/Employee
$1,432.77
Loading...
Loading...
Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. It focuses on Fully Human Albumin Binding (FHAB) technology which utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2011 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
13

Frequently Asked Questions

What is Market Cap of Sonnet BioTherapeutics Holdings Inc?
What is the 52-week high for Sonnet BioTherapeutics Holdings Inc?
What is the 52-week low for Sonnet BioTherapeutics Holdings Inc?
What is Sonnet BioTherapeutics Holdings Inc stock price today?
What was Sonnet BioTherapeutics Holdings Inc stock price yesterday?
What is the PE ratio of Sonnet BioTherapeutics Holdings Inc?
What is the Price-to-Book ratio of Sonnet BioTherapeutics Holdings Inc?
What is the 50-day moving average of Sonnet BioTherapeutics Holdings Inc?
How many employess does Sonnet BioTherapeutics Holdings Inc has?

Latest SONN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.